Chemokine receptors and the control of Th17-mediated inflammation

趋化因子受体和 Th17 介导的炎症的控制

• 批准号: nhmrc : 1066781
• 负责人: Dr Iain Comerford
• 金额: $ 53.43万
• 依托单位: The University of Adelaide
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/chemokine-receptors-control-mediated-inflammation/455258
• 关键词: Chemokine; receptors; control; Th17; mediated

Controlling persistent inflammation in autoimmune diseases is a major challenge and current therapeutics have significant side effects. Thus, novel targets must be identified. We have discovered a previously unknown level of control of autoimmune inflammation that may represent a more specific and effective means of controlling ongoing inflammation in these diseases.

控制自身免疫性疾病中的持续性炎症是一项重大挑战，目前的治疗方法具有显著的副作用。因此，必须确定新的目标。我们已经发现了一种以前未知的自身免疫性炎症控制水平，这可能代表了一种更特异和有效的控制这些疾病中持续炎症的方法。